Cytogenetics are a predictive factor of response to low dose Ara-C in acute myelogenous leukemia (AML) in the elderly.
Fenaux
P
P
Lai
J L
JL
Gardin
C
C
Bauters
F
F
D000368:Aged; D003561:Cytarabine / Q000627:therapeutic use*; D005260:Female; D015321:Gene Rearrangement; D006801:Humans; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008875:Middle Aged
D003561:Cytarabine